These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36556184)

  • 1. Long-Term Follow-Up in IgG4-Related Ophthalmic Disease: Serum IgG4 Levels and Their Clinical Relevance.
    Chou WY; Tsai CY; Tsai CC
    J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease.
    Hong JW; Kang S; Song MK; Ahn CJ; Sa HS
    Br J Ophthalmol; 2018 Nov; 102(11):1591-1595. PubMed ID: 29420193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients.
    Gan L; Luo X; Fei Y; Peng L; Zhou J; Li J; Lu H; Liu Z; Zhang P; Liu X; Zhang W
    BMC Ophthalmol; 2021 Dec; 21(1):447. PubMed ID: 34961492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological count of IgG4-positive plasmacytes suggests extraophthalmic involvement and relapse in patients with IgG4-related ophthalmic disease: a retrospective study.
    Yuan Y; Meng F; Ren H; Yue H; Xue K; Zhang R
    Arthritis Res Ther; 2022 Apr; 24(1):80. PubMed ID: 35365184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of patients with orbital nonspecific inflammatory response diseases whose CT or MR images show enlargement of the infraorbital nerves].
    Zhao L; Tang DR; Wu T; Jian TM; Lin TT; Sun FY
    Zhonghua Yan Ke Za Zhi; 2018 Jul; 54(7):515-519. PubMed ID: 29996613
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects.
    McNab AA; McKelvie P
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):167-78. PubMed ID: 25564258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the Clinical Features and Outcomes of IgG4-Related Ophthalmic Disease.
    Kim D; Jeong S; Lew H
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999348
    [No Abstract]   [Full Text] [Related]  

  • 8. Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.
    Ebbo M; Patient M; Grados A; Groh M; Desblaches J; Hachulla E; Saadoun D; Audia S; Rigolet A; Terrier B; Perlat A; Guillaud C; Renou F; Bernit E; Costedoat-Chalumeau N; Harlé JR; Schleinitz N
    Medicine (Baltimore); 2017 Mar; 96(10):e6205. PubMed ID: 28272212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids.
    Yu WK; Kao SC; Yang CF; Lee FL; Tsai CC
    Jpn J Ophthalmol; 2015 Jan; 59(1):8-13. PubMed ID: 25373451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and pathological study on IgG4-related ophthalmic disease involving the lacrimal gland].
    Li HQ; Lin JY; Zhao H
    Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):834-841. PubMed ID: 31715680
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical analysis of ocular adnexal mucosa-associated lymphoid tissue lymphoma with IgG4-related ophthalmic disease.
    Yoon J; Kim KJ; Sa HS
    Orbit; 2022 Oct; 41(5):551-557. PubMed ID: 34369286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for extraophthalmic involvement and treatment outcomes in patients with IgG4-related ophthalmic disease.
    Park J; Lee MJ; Kim N; Kim JE; Park SW; Choung HK; Khwarg SI
    Br J Ophthalmol; 2018 Jun; 102(6):736-741. PubMed ID: 28972022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of IgG4-Related Ophthalmic Disease and Idiopathic Sclerosing Orbital Inflammation.
    Son KY; Woo KI; Kim YD
    Ophthalmic Plast Reconstr Surg; 2022 Jan-Feb 01; 38(1):34-39. PubMed ID: 33782329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and symptoms of IgG4-related ophthalmic disease: a multicenter study.
    Goto H; Ueda SI; Nemoto R; Ohshima KI; Sogabe Y; Kitagawa K; Ogawa Y; Oyama T; Furuta M; Azumi A; Takahira M
    Jpn J Ophthalmol; 2021 Sep; 65(5):651-656. PubMed ID: 34146222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic Cross-Sectional Imaging Features of IgG4-Related Orbitopathy in Comparison to Ocular Adnexal Lymphoma.
    Klingenstein A; Garip-Kuebler A; Priglinger S; Hintschich C; Mueller-Lisse UG
    Clin Ophthalmol; 2021; 15():1119-1127. PubMed ID: 33737803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.
    Wallace ZS; Deshpande V; Stone JH
    Semin Arthritis Rheum; 2014 Jun; 43(6):806-17. PubMed ID: 24513111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease.
    Takahira M; Goto H; Azumi A
    Jpn J Ophthalmol; 2024 Jul; ():. PubMed ID: 39037515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes of IgG4-Related Ophthalmic Disease in a Chinese IgG4-Related Disease Cohort.
    Gan L; Luo X; Fei Y; Peng L; Zhou J; Li J; Lu H; Liu Z; Zhang P; Liu X; Zhang W
    Front Med (Lausanne); 2021; 8():784520. PubMed ID: 34977087
    [No Abstract]   [Full Text] [Related]  

  • 19. Cases with IgG4-related ophthalmic disease with mass lesions surrounding the optic nerve.
    Hamaoka S; Takahira M; Kawano M; Yamada K; Inoue D; Okuda T; Sugiyama K
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101324. PubMed ID: 35146198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of serum IgG
    Woo YJ; Kim JW; Yoon JS
    Br J Ophthalmol; 2017 Mar; 101(3):256-260. PubMed ID: 27215743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.